[1]Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al.Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People[J].Age Ageing, 2010, 39(4):412-23
[2]Sabatino A, Regolisti G, Delsante M, et al.Noninvasive evaluation of muscle mass by ultrasonography of quadriceps femoris muscle in End-Stage Renal Disease patients on hemodialysis[J].Clin Nutr, 2019, 38(3):1232-9
[3]Chen LK, Liu LK, Woo J, et al.Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia[J].J Am Med Dir Assoc, 2014, 15(2):95-101
[4]Cruz-Jentoft AJ, Bahat G, Bauer J, et al.Sarcopenia: revised European consensus on definition and diagnosis[J].Age Ageing, 2019, 48(1):16-31
[5]Fielding RA, Vellas B, Evans WJ, et al.Sarcopenia: an undiagnosed condition in older adultsCurrent consensus definition: prevalence,etiology,and consequences. International working group on sarcopenia[J].J Am Med Dir Assoc, 2011, 12(4):249-56
[6]Studenski SA, Peters KW, Alley DE, et al.The FNIH sarcopenia project: rationale,study description,conference recommendations,and final estimates[J].J Gerontol A Biol Sci Med Sci, 2014, 69(5):547-58
[7]Chen LK, Woo J, Assantachai P, et al.Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment[J].J Am Med Dir Assoc, 2020, 21(3):300-7
[8]Shu X, Lin T, Wang H, et al.Diagnosis,prevalence,and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis[J].J Cachexia Sarcopenia Muscle, 2022, 13(1):145-58
[9]Lin YL, Liou HH, Wang CH, et al.Impact of sarcopenia and its diagnostic criteria on hospitalization and mortality in chronic hemodialysis patients: A 3-year longitudinal study[J].J Formos Med Assoc, 2020, 119(7):1219-29
[10]Sabatino A, Cuppari L, Stenvinkel P, et al.Sarcopenia in chronic kidney disease: what have we learned so far?[J].J Nephrol, 2021, 34(4):1347-72
[11]Wang XH, Mitch WE.Mechanisms of muscle wasting in chronic kidney disease[J].Nat Rev Nephrol, 2014, 10(9):504-16
[12]Mitch WE, Goldberg AL.Mechanisms of muscle wastingThe role of the ubiquitin-proteasome pathway[J].N Engl J Med, 1996, 335(25):1897-905
[13]Bataille S, Chauveau P, Fouque D, et al.Myostatin and muscle atrophy during chronic kidney disease[J].Nephrol Dial Transplant, 2021, 36(11):1986-93
[14]Du J, Wang X, Miereles C, et al.Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions[J].J Clin Invest, 2004, 113(1):115-23
[15]Sandri M.Autophagy in health and disease3. Involvement of autophagy in muscle atrophy[J].Am J Physiol Cell Physiol, 2010, 298(6):C1291-7
[16]Sandri M.Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome[J].Int J Biochem Cell Biol, 2013, 45(10):2121-9
[17]Gordon BS, Kelleher AR, Kimball SR.Regulation of muscle protein synthesis and the effects of catabolic states[J].Int J Biochem Cell Biol, 2013, 45(10):2147-57
[18]Schardong J, Marcolino MAZ, Plentz RDM.Muscle Atrophy in Chronic Kidney Disease[J].Adv Exp Med Biol, 2018, 1088:393-412.
[19]Cheng TC, Huang SH, Kao CL, et al.Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical Implications-A Narrative Review[J].Int J Mol Sci, 2022, 23(11):-
[20]Robinson KA, Baker LA, Graham-Brown MPM, et al.Skeletal muscle wasting in chronic kidney disease: the emerging role of microRNAs[J].Nephrol Dial Transplant, 2020, 35(9):1469-78
[21]Deger SM, Hung AM, Gamboa JL, et al.Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients[J].JCI Insight, 2017, 2(22):-
[22]Amitani M, Asakawa A, Amitani H, et al.Control of food intake and muscle wasting in cachexia[J].Int J Biochem Cell Biol, 2013, 45(10):2179-85
[23]Cobo G, Lindholm B, Stenvinkel P.Chronic inflammation in end-stage renal disease and dialysis[J].Nephrol Dial Transplant, 2018, 33(suppl_3):i-i
[24]Wang AY.Consequences of chronic inflammation in peritoneal dialysis[J].Semin Nephrol, 2011, 31(2):159-71
[25]Garagarza C, Valente A, Caetano C, et al.Dietary Intake,Body Composition,and Clinical Parameters: Associations Between the Level and Type of Physical Activity in Hemodialysis Patients[J].J Phys Act Health, 2021, 18(10):1223-30
[26]Gungor O, Ulu S, Hasbal NB, et al.Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?[J].J Cachexia Sarcopenia Muscle, 2021, 12(6):1380-92
[27]Gibson NR, Fereday A, Cox M, et al.Influences of dietary energy and protein on leucine kinetics during feeding in healthy adults[J].Am J Physiol, 1996, 270(2 Pt 1):E282-91
[28]Copur S, Sag AA, Afsar B, et al.Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primer[J].Int Urol Nephrol, 2020, 52(12):2311-20
[29]Brüggemann AK, Mello CL, Dal Pont T, et al.Effects of Neuromuscular Electrical Stimulation During Hemodialysis on Peripheral Muscle Strength and Exercise Capacity: A Randomized Clinical Trial[J].Arch Phys Med Rehabil, 2017, 98(5):822-31
[30]Hewitt NA, O' Connor AA, O' Shaughnessy DV, et al.Effects of cholecalciferol on functional,biochemical,vascular,and quality of life outcomes in hemodialysis patients[J].Clin J Am Soc Nephrol, 2013, 8(7):1143-1149
[31]Muramatsu H, Kuramochi T, Katada H, et al.Novel myostatin-specific antibody enhances muscle strength in muscle disease models[J].Sci Rep, 2021, 11(1):2160-
[32]Lin YL, Chen SY, Lai YH, et al.Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients[J].BMC Nephrol, 2019, 20(1):54-
